Nicotine metabolite ratio as a predictor of CYP2A6 phenotypic activity.

被引：0
|
作者：
Dempsey, DA [1 ]
Tutka, P [1 ]
Jacob, P [1 ]
Benowitz, NL [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2002年 / 71卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P24 / P24
页数：1
相关论文
共 50 条
  • [21] DISTRIBUTION OF POLYMORPHIC VARIANTS OF CYP2A6 AND THEIR INVOLVEMENT IN NICOTINE ADDICTION
    Lopez-Flores, Luis A.
    Perez-Rubio, Gloria
    Falfan-Valencia, Ramces
    EXCLI JOURNAL, 2017, 16 : 174 - 196
  • [22] Effects of whole deletion of CYP2A6 on nicotine metabolism in humans
    Zhang, X
    Ameno, K
    Ameno, S
    Kinoshita, H
    Kubota, T
    Kumihashi, M
    Mostofa, J
    Iwahashi, K
    Ijiri, I
    DRUG AND CHEMICAL TOXICOLOGY, 2002, 25 (02) : 203 - 213
  • [23] In silico development of inhibitors of the nicotine metabolising CYP2A6 enzyme
    Rahnasto, M
    Poso, A
    Raunio, H
    Juvonen, RO
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 285 - 285
  • [24] Grapefruit juice inhibits CYP2A6 and nicotine metabolism.
    Hukkanen, J
    Benowitz, NL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P75 - P75
  • [25] CYP2A6 genotype and toxicity of nicotine in never smokers.
    Dempsey, DA
    Jacob, P
    Tyndale, RF
    Hoffmann, E
    Benowitz, NL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P4 - P4
  • [26] Nicotine metabolite ratio as a predictor of cigarette consumption
    Benowitz, NL
    Pomerleau, OF
    Pomerleau, CS
    Jacob, P
    NICOTINE & TOBACCO RESEARCH, 2003, 5 (05) : 621 - 624
  • [27] Genetic polymorphisms and phenotypic analysis of CYP2A6 in the Sherpa population
    He, Xue
    Sun, Fang
    Zhang, Ning
    Zhu, Xikai
    Ma, Lifeng
    Zhang, Xiyang
    Zhang, Yuan
    Kang, Longli
    Jin, Tianbo
    Yuan, Dongya
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10474 - 10482
  • [28] Functional Characterization of Cytochrome P450 2A6 Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21, and CYP2A6*22
    Tiong, Kai Hung
    Yiap, Beow Chin
    Tan, Eng Lai
    Ismail, Rusli
    Ong, Chin Eng
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (05) : 745 - 751
  • [29] Effects of chronic nicotine treatment on CYP2A6, CYP2B6, and nicotine/cotinine metabolism in African Green monkeys
    Schoedel, KA
    Miksys, S
    Nolte, H
    Sellers, EM
    Nwaneshiudu, A
    Tyndale, RF
    FASEB JOURNAL, 2001, 15 (04): : A573 - A573
  • [30] Variation in CYP2A6 Activity and Personalized Medicine
    Tanner, Julie-Anne
    Tyndale, Rachel F.
    JOURNAL OF PERSONALIZED MEDICINE, 2017, 7 (04):
12345